Page 48

2026-05-07 · 2026-05 / week-1

Cellectar Is Trading Above Its Warrant Call Line

Summary: Cellectar's clinical update is real, but the common stock is now trading above the mechanical level that can turn the financing into a wall of $2.65 stock. The disagreement is not whether iopofosine I 131 has en...

2026-05-07 · 2026-05 / week-1

Avalo Is Pricing Phase 3 Before the Share Count Settles

Summary: AVTX now trades as if the positive Phase 2 LOTUS readout has already crossed the bridge into a funded Phase 3 story. The harder mispricing is that the $21.81 quote sits 22.9% above a $17.75 overnight offering wh...

2026-05-06 · 2026-05 / week-1

Stratus Is Pricing the Liquidation Floor

Summary: Stratus Properties is asking holders to approve a complete liquidation on June 1. The stock is trading at $29.68, almost exactly at the company's estimated low-end liquidating distribution of $29.73, while the h...

2026-05-06 · 2026-05 / week-1

Rumble Is Pricing AI Approval, but Northern Data Owns the Float

Summary: Rumble has cleared the last regulatory condition for the Northern Data exchange offer, and the stock is still trading like the deal is mainly an AI capacity win. The harder setup is mechanical: the offer documen...

2026-05-06 · 2026-05 / week-1

NFJ Is Pricing a Dividend Fund, Not a September Cash Exit

Summary: Virtus Dividend, Interest & Premium Strategy Fund is still trading like an income CEF with a tighter discount. The mispricing is that a board-approved September tender turns part of the discount into a dated cas...

2026-05-06 · 2026-05 / week-1

The Market Is Pricing NewBird AI, but the Proxy Prices a Shell

Summary: Allbirds is no longer a footwear turnaround. The common now trades as a bundle of a management-estimated $1.34 asset-sale distribution and a NewBird AI stub whose implied value is much larger than the pro forma ...

2026-05-06 · 2026-05 / week-1

Lisata Is Pricing a Broken Tender Before Kuva Runs Out of Clock

Summary: Lisata trades at $3.27 against Kuva's signed $5.00 cash offer plus a non-tradeable $1.00 certepetide CVR. The discount is not a normal merger spread. It is the market saying that a private buyer that already mis...

2026-05-06 · 2026-05 / week-1

Kezar Is No Longer Just a Cash Tender

Summary: KZR is trading above Aurinia's $6.955 cash tender price because the market is assigning value to a nontransferable CVR. The disagreement is whether the CVR is a small biotech lottery ticket or a near-term claim ...

2026-05-06 · 2026-05 / week-1

Hyperion DeFi Is Pricing HYPE, but Dilution Owns the Float

Summary: Hyperion DeFi looks like a cheap public wrapper on Hyperliquid's HYPE token if the analysis stops at basic shares. The disagreement appears only after the warrant stack, the new May 5 offering, and the remaining...

2026-05-06 · 2026-05 / week-1

Hexagon Is Pricing the Spin, but Octave Owns the Clock

Why this one now: The market has less than three trading weeks before Hexagon goes ex-entitlement, while Octave has a live Form 10, a fixed distribution ratio, an SDR bridge, and published index-treatment mechanics.

2026-05-06 · 2026-05 / week-1

CXH Is Pricing the Tender, but Proration Owns the Clock

Summary: MFS Investment Grade Municipal Trust is trading near $8.35 against a May 12 tender for up to 50% of its shares at 99% of NAV. The market appears to see a clean discount-capture event; the real trade is a prorati...